506 related articles for article (PubMed ID: 19183164)
1. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract.
Fernández-Rivas M; Garrido Fernández S; Nadal JA; Díaz de Durana MD; García BE; González-Mancebo E; Martín S; Barber D; Rico P; Tabar AI
Allergy; 2009 Jun; 64(6):876-83. PubMed ID: 19183164
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy in peach allergy: monitoring molecular sensitizations and reactivity to apple fruit and Platanus pollen.
García BE; González-Mancebo E; Barber D; Martín S; Tabar AI; Díaz de Durana AM; Garrido-Fernández S; Salcedo G; Rico P; Fernández-Rivas M
J Investig Allergol Clin Immunol; 2010; 20(6):514-20. PubMed ID: 21243936
[TBL] [Abstract][Full Text] [Related]
3. Are basophil activation and sulphidoleukotriene determination useful tests for monitoring patients with peach allergy receiving sublingual immunotherapy with a Pru p 3-enriched peach extract?
Garrido-Fernández S; García BE; Sanz ML; Echechipía S; Lizaso MT; Tabar AI
J Investig Allergol Clin Immunol; 2014; 24(2):106-13. PubMed ID: 24834773
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
Enrique E; Pineda F; Malek T; Bartra J; Basagaña M; Tella R; Castelló JV; Alonso R; de Mateo JA; Cerdá-Trias T; San Miguel-Moncín Mdel M; Monzón S; García M; Palacios R; Cisteró-Bahíma A
J Allergy Clin Immunol; 2005 Nov; 116(5):1073-9. PubMed ID: 16275379
[TBL] [Abstract][Full Text] [Related]
5. Clinical, anamnestic and serological features of peach allergy in portugal.
Rodrigues-Alves R; Lopez A; Pereira-Santos MC; Lopes-Silva S; Spínola-Santos A; Costa C; Branco-Ferreira M; Lidholm J; Pereira-Barbosa M
Int Arch Allergy Immunol; 2009; 149(1):65-73. PubMed ID: 19033734
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
7. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
8. The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions.
Gomez F; Bogas G; Gonzalez M; Campo P; Salas M; Diaz-Perales A; Rodriguez MJ; Prieto A; Barber D; Blanca M; Torres MJ; Mayorga C
Clin Exp Allergy; 2017 Mar; 47(3):339-350. PubMed ID: 28160513
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
10. Food allergy to apple and specific immunotherapy with birch pollen.
Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
[TBL] [Abstract][Full Text] [Related]
11. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
13. Identification of a plane pollen lipid transfer protein (Pla a 3) and its immunological relation to the peach lipid-transfer protein, Pru p 3.
Lauer I; Miguel-Moncin MS; Abel T; Foetisch K; Hartz C; Fortunato D; Cistero-Bahima A; Vieths S; Scheurer S
Clin Exp Allergy; 2007 Feb; 37(2):261-9. PubMed ID: 17250699
[TBL] [Abstract][Full Text] [Related]
14. Cabbage lipid transfer protein Bra o 3 is a major allergen responsible for cross-reactivity between plant foods and pollens.
Palacín A; Cumplido J; Figueroa J; Ahrazem O; Sánchez-Monge R; Carrillo T; Salcedo G; Blanco C
J Allergy Clin Immunol; 2006 Jun; 117(6):1423-9. PubMed ID: 16751008
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.
Srivastava D; Singh BP; Sudha VT; Arora N; Gaur SN
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):273-80. PubMed ID: 17910332
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
[TBL] [Abstract][Full Text] [Related]
18. Pru p 3-sensitised Italian peach-allergic patients are less likely to develop severe symptoms when also presenting IgE antibodies to Pru p 1 and Pru p 4.
Pastorello EA; Farioli L; Pravettoni V; Scibilia J; Mascheri A; Borgonovo L; Piantanida M; Primavesi L; Stafylaraki C; Pasqualetti S; Schroeder J; Nichelatti M; Marocchi A
Int Arch Allergy Immunol; 2011; 156(4):362-72. PubMed ID: 21829031
[TBL] [Abstract][Full Text] [Related]
19. Natural rubber latex allergy in children: clinical and immunological effects of 3-years sublingual immunotherapy.
Bernardini R; Pecora S; Milani M; Burastero SE
Eur Ann Allergy Clin Immunol; 2008 Dec; 40(4):142-7. PubMed ID: 19227650
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
